Literature DB >> 18294113

Iron overload disorders: treatment options for patients refractory to or intolerant of phlebotomy.

Penny Bring1, Nilufar Partovi, Jo-Ann E Ford, Eric M Yoshida.   

Abstract

Iron overload disorders involve excess accumulation of iron in body tissues as a result of hereditary and nonhereditary diseases. If left untreated, tissue iron deposition can result in organ damage. Treatment options such as phlebotomy, chelating agents, and erythrocytapheresis can prevent complications and target organ damage. Although phlebotomy is the gold standard for iron overload treatment in the setting of hereditary hemochromatosis, this procedure is usually not feasible for other iron overload conditions, especially those associated with anemia. With the introduction of newer, oral chelating agents, more options are available for patients refractory to or intolerant of parenteral chelating agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18294113     DOI: 10.1592/phco.28.3.331

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  8 in total

1.  Frequencies of HFE gene mutations associated with haemochromatosis in the population of Libya living in Benghazi.

Authors:  Samir Elmrghni; Ron A Dixon; D Ross Williams
Journal:  Int J Clin Exp Med       Date:  2011-09-15

2.  Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups.

Authors:  Jongdoo Lim; Vincent J Venditto; Eric E Simanek
Journal:  Bioorg Med Chem       Date:  2010-05-20       Impact factor: 3.641

Review 3.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

4.  Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model.

Authors:  Pablo A Valdés; Kimberley Samkoe; Julia A O'Hara; David W Roberts; Keith D Paulsen; Brian W Pogue
Journal:  Photochem Photobiol       Date:  2009-12-07       Impact factor: 3.421

5.  Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

Authors:  Satoru Oshiro; Masaki S Morioka; Masataka Kikuchi
Journal:  Adv Pharmacol Sci       Date:  2011-10-12

6.  Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation.

Authors:  Wenqian Wang; Kouichi Tabu; Yuichiro Hagiya; Yuta Sugiyama; Yasuhiro Kokubu; Yoshitaka Murota; Shun-Ichiro Ogura; Tetsuya Taga
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

7.  A late presentation of a fatal disease: juvenile hemochromatosis.

Authors:  Cynthia Cherfane; Pauline Lee; Leana Guerin; Kyle Brown
Journal:  Case Rep Med       Date:  2013-09-11

Review 8.  Management of Iron Overload in Resource Poor Nations: A Systematic Review of Phlebotomy and Natural Chelators.

Authors:  Orish Ebere Orisakwe; Cecilia Nwadiuto Amadi; Chiara Frazzoli
Journal:  J Toxicol       Date:  2020-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.